# Epigenetic Evaluation of HAT/HDAC Activity in PBMC From Patients With Clinically Isolated Syndrome

> **NCT02862301** · NA · UNKNOWN · sponsor: **Centre Hospitalier Universitaire de Besancon** · enrollment: 55 (estimated)

## Conditions studied

- Demyelinating Autoimmune Diseases, CNS

## Interventions

- **BIOLOGICAL:** blood sample

## Key facts

- **NCT ID:** NCT02862301
- **Lead sponsor:** Centre Hospitalier Universitaire de Besancon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-04
- **Primary completion:** 2020-06
- **Final completion:** 2020-09
- **Target enrollment:** 55 (ESTIMATED)
- **Last updated:** 2019-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02862301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02862301, "Epigenetic Evaluation of HAT/HDAC Activity in PBMC From Patients With Clinically Isolated Syndrome". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02862301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*